NEWS!.........Still waiting for one of those "milestones".
Synthetic Blood International Inc. Retains Public Relations Firm
Business Wire - October 13, 1998 09:20
KETTERING, Ohio--(BUSINESS WIRE)--Oct. 13, 1998--Synthetic Blood International Inc. (OTCBB:SYBD), has retained Royal Public Relations Co. of St. Louis to handle its public relations activities with investors, the news media, stock brokers and stock analysts.
Royal Public Relations Co. was established 25 years ago by Donald L. Roth, its president. Prior to entering the public relations field, Roth was a reporter and editor for the Associated Press and the "St. Louis Globe-Democrat" and "Kansas City Star" newspapers. His company has handled public relations for several New York Stock Exchange and American Stock Exchange companies, plus Nasdaq-listed corporations.
"We are pleased to add an experienced public relations arm to our company to help relate significant developments in the rebuilding of SYBD. Don Roth's experience and contacts will be invaluable as we seek to more effectively communicate achievement of major milestones over the next year," said Robert Nicora, president and chief executive officer of Synthetic Blood International.
SYBD is developing Oxycyte(TM), a perfluorocarbon blood substitute emulsion; Fluorovent(TM), a perfluorocarbon liquid ventilation product, and an implanted biosensor for continuous monitoring of blood glucose levels in diabetics.
Synthetic Blood International is located in Kettering, Ohio, with its West Coast offices based in Newport Beach, Calif. The company's stock is traded on the OTC Electronic Bulletin Board, symbol SYBD. The company's web site is sybd.com and its e-mail address is sybd@siscom.net.
CONTACT: Synthetic Blood International Inc.
Joan Mahan, 800/809-6054 |
